Valuation (21%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 19.85 | N/A |
| PEG Ratio (TTM) | -1.21 | N/A |
| P/S Ratio (TTM) | N/A | N/A |
| P/B Ratio (TTM) | 3.42 | N/A |
| P/FCF Ratio (TTM) | -119.21 | N/A |
| Price to 5YR AVG Earnings Ratio | N/A | N/A |
| Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (35%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 12.46% | N/A |
| ROE (TTM) | 18.52% | N/A |
| Net Profit Margin (TTM) | N/A | N/A |
| ROIC 5YR AVG | N/A | N/A |
Growth (8%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 10.63% | N/A | N/A |
| Revenue | N/A | N/A | N/A |
| Net Income | -11.97% | N/A | N/A |
| Cash Flow | -130.43% | N/A | N/A |
Health (42%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.27 | N/A |
| Quick Ratio (TTM) | 0.27 | N/A |
| D/E Ratio (TTM) | 0.03 | N/A |
| Interest Coverage (TTM) | 2.37 | N/A |
| Piotroski F-Score | 4 | N/A |
| Altman Z-Score | 5.20 | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | N/A | N/A |